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 Cardio-Pulmonary Exercise Test in Myocardial Ischaemia Detection 
 
Abstract: 
Exercise electrocardiography has low sensitivity for detection of myocardial ischaemia. 
However, when combined with cardio-pulmonary exercise testing (CPEX) the sensitivity and 
specificity of ischaemia detection improves significantly.  
CPEX offers unique advantages over imaging techniques in tricky situations such as balanced 
ischemia. Early abnormal oxygen uptake would point towards profound coronary stenosis, 
that could be missed in perfusion imaging.  
CPEX could be an invaluable tool in asymptomatic left bundle branch block (LBBB) pattern, 
without exposing patients to the risks of CT or invasive coronary angiography. Normal 
oxygen uptake curves would rule-out significant coronary stenosis as the cause of LBBB 
pattern. Else ways, abnormal oxygen uptake in patients with normal coronary arteries could 
indicate microvascular angina. Furthermore, exercise capacity is an excellent predictor of 
cardiovascular risk in those with and without heart disease. 
Using two clinical cases we introduce the concept of gas-exchange and haemodynamic 
changes encountered in ischaemic heart disease. 
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Cardiac ischaemia can present with a variety of symptoms including chest pain, arm pain and 
breathlessness, or may be ‘silent’ [1]. Exertional symptoms raise the suspicion of coronary 
ischaemia due to the associated increase in the cardiac work and unmet energetic demands of 
the ischaemic myocardium [2]. The practice of exercise electrocardiogram (ECG) testing  aims 
to reproduce the symptoms in a controlled environment and gives the physician excellent 
insight into cardio-respiratory function during stress [3]. However, recent guidelines removed 
exercise ECG testing from being the first line investigation for angina, due to relatively poor 
sensitivity and specificity [2, 4]. Cardio-pulmonary exercise testing (CPEX) measures gas-
exchange in addition to the usual exercise parameters. It provides incremental information on 
cardiovascular and respiratory physiology. Recent studies have explored the utility of CPEX 
as an investigational tool for angina. With the help of two clinical cases we will describe the 
usefulness of CPEX in the investigation coronary artery disease. Supplementary table 1 shows 
the commonly used abbreviations in CPEX [5]. 
Case 1 
A 64-year-old man presented with progressive breathlessness on exertion. He was treated for 
prostate cancer but had no other history. His cardiovascular clinical examination was 
unremarkable. Resting ECG, echocardiogram and full blood count were normal. On a routine 
treadmill exercise stress there were no significant ECG changes. A CPEX was then performed 
with a standard incremental step protocol on a treadmill using a COSMED CPEX (Italy) 
system. Spirometry prior to the test was normal. The total exercise duration was 9 minutes and 
40 seconds. His gas-exchange results are shown below in Table 1. A typical treadmill exercise 
protocol as utilised in this patient is shown in supplementary table 2 [5].   







There were no ECG changes suggestive of coronary ischaemia during peak exercise or 
recovery. Although the absolute values of gas-exchange were normal, abrupt flattening of the 
oxygen consumption and oxygen pulse (O2pulse) were noticed close to peak exercise (Figure1). 
O2 pulse, a common term in CPEX, is calculated by dividing oxygen consumption by 
simultaneously measured heart rate [6]. O2 pulse progressively increases during exercise and 
promptly falls on stopping [6]. O2 pulse has been shown to be a surrogate for stroke volume 
[7]. In patients with cardiac ischaemia, on reaching the ischemic threshold, a reduction in stroke 
volume due to myocardial dysfunction may result in impaired oxygen delivery (and hence 
consumption) which is reflected as an abrupt flattening of the O2 pulse [8, 9]. Rapid 
improvement in left ventricular systolic function on cessation of exercise in those with 
significant coronary disease, also contributes to a delayed systolic blood pressure recovery after 
exercise [10].  
 
Furthermore, there was an increase in oxygen consumption during early recovery. In a failing 
heart due to ischaemia, a paradoxical rise in O2 pulse occurs on stopping the exercise, resulting 
from improved cardiac function due to relief of ischaemia [11]. A coronary angiography later 
showed significant stenosis in dominant right coronary artery, which was successfully stented, 
with resolution of breathlessness.  
Figure 1 Oxygen and carbon-dioxide uptake curves (case 1) 
Case 2 
A 61 year old woman was referred to cardiac outpatients because of retrosternal chest pain, 
unrelated to exertion. An ECG showed left bundle branch block (LBBB) pattern. The 
echocardiogram was unremarkable apart from abnormal septal motion typical of LBBB 







RAMP protocol. Spirometry prior to the test was normal. She exercised for 11 minutes and 58 
seconds. Gas exchange results are shown in Table 2. 
Table 2 Gas-exchange and haemodynamic parameters (case 2) 
 
Her absolute values of gas-exchange were within normal limits. Figure 2 shows her oxygen 
uptake profile. Figure 2A shows steady increase in absolute oxygen consumption throughout 
exercise. Figure 2B shows steady increase in O2 pulse, suggesting that there is no significant 
reduction in stroke volume during exercise. Figure 2C shows oxygen uptake as a function of 
work-rate (O2/ΔWR). In healthy subjects the normal oxygen uptake is 10 ml/min/Watt and this 
increase is a linear function throughout exercise [12]. In contrast in patients who develop severe 
cardiac ischaemia during exercise resulting in a sudden fall in cardiac output, oxygen delivery 
is impeded and anaerobic metabolism contributes significantly to the ATP generation [13]. 
This results in relative flattening of the O2/ΔWR, despite increasing workload and is another 
useful marker in suspecting coronary ischaemia [8]. It has been shown in those with coronary 
ischaemia, the flattening of O2/ΔWR usually correlates with the flattening of the O2 pulse, 
indicating the onset of ischemic myocardial dysfunction [8, 9]. The O2/ΔWR is obtainable only 
on bicycle CPEX and not on treadmill CPEX. CT (computerised tomography) coronary 
angiography later confirmed normal coronary arteries.  
Figure 2 Oxygen and carbon-dioxide uptake curves (case 2) 
Discussion: 
The latest European Society of Cardiology guidelines discounted exercise ECG testing as an 
investigation for suspected angina, due to lack of sensitivity and specificity [4]. We discuss 
how the addition of ventilatory parameters in CPEX can be an additional diagnostic toll in the 







Exercise ECG testing has traditionally been used in the investigation of suspected coronary 
artery disease. Until the last decade, it was the recommended first line tool for those with 
intermediate probability for coronary artery disease [14]. Apart from reproduction of patient 
symptoms in a controlled environment, exercise testing provides other valuable information 
including time to symptom onset, exercise induced arrhythmias, blood pressure and 
chronotropic response to exercise [14, 15]. Exercise capacity is an excellent predictor of cardio-
vascular risk including mortality in both healthy subjects and in those with coronary artery 
disease [15]. Exercise ECG test is equivalent to that of myocardial perfusion imaging in 
predicting major adverse cardiovascular events, in those with suspected coronary artery disease 
[16]. However, during the myocardial ischemic cascade, metabolic abnormalities, diastolic 
dysfunction, systolic dysfunction and ECG changes occur in a sequential manner [17]. ECG 
changes occur late after systolic impairment, which explains the low sensitivity (60-70%) [18]. 
ST depression is only a functional sign of inadequate oxygen supply to meet the myocardial 
demands, and could occur in anaemia, lung disease or when the myocardial oxygen demand is 
high, as in left ventricular hypertrophy [19]. Hence the specificity of exercise testing is also 
poor (70-80%) [18]. The sensitivity and specificity are even lower in women [20]. 
Furthermore, there are interpretation difficulties in those with resting ECG abnormalities 
including resting ST segment depression, left ventricular hypertrophy, left bundle branch 
block, interventricular conduction abnormalities, Wolf-Parkinson White pattern and those on 
beta-blocker or Digoxin therapy [14, 20].  
Bruce, who standardised treadmill exercise testing was one of the earliest to recognise that 
oxygen consumption at peak exercise (pVO2) is reduced in patients with coronary artery 
disease[21]. Ehsani et al (1984) showed that in those with coronary artery disease, a reduction 







that pVO2 and O2 pulse were lower in coronary ischemia, compared to controls [23]. Klainman 
(1998) and later Inbar (2008) demonstrated that successful coronary angioplasty, improved 
pVO2, anaerobic threshold and oxygen pulse [24]. CPEX could be also useful in diagnosing 
coronary artery disease in asymptomatic diabetic women. Smanio et al showed that CPEX is 
better than routine ECG stress testing in this cohort, but inferior to myocardial perfusion 
imaging [25]. Furthermore, CPEX has shown to be useful in assessing new medical therapies 
for coronary artery disease [26]. 
However, it was Belardinelli et al who delivered a convincing case for CPEX with two 
landmark papers. In his first study, he investigated two CPEX parameters - O2 pulse and 
O2/ΔWR, in angina patients [8].  
1) Abrupt flattening of O2/ΔWR slope (Figure 3B). The normal relationship is linear with a 
value of 10 ml/min/W. Belardinelli chose a cut-off of slope < 3.9 ml/min/W to detect the 
onset of ischaemia [8] 
2) Concomitant flattening of O2 pulse (Figure 3A) 
His group compared CPEX and ECG testing against exercise stress myocardial perfusion 
imaging (MPI) [8]. Patients with proven coronary artery disease demonstrated by invasive 
angiography, underwent CPEX and MPI for ischaemia testing. In 140 patients in whom MPI 
demonstrated ischaemia, CPEX correctly diagnosed ischaemia in 122 and among 62 patients 
who did not have perfusion defects, CPEX correctly ruled out ischaemia in 46. And had a 
superior sensitivity (89% vs 46%) and specificity (74% vs 66%) compared to ECG changes 
alone.  








In 2014, Belardinelli et al conducted another elegant study in out-patients referred to cardiology 
with chest pain. He performed MPI and invasive angiography on 73 patients with CPEX proven 
ischaemia and 71 patients in whom CPEX had ruled out ischaemia [9]. He showed CPEX 
parameters had a significantly higher sensitivity (88% vs 48%) and specificity (98% vs 55%) 
compared to ECG parameters alone. Myocardial dysfunction in the setting of coronary artery 
disease also results in inappropriately higher heart rate response to exercise, as a compensatory 
mechanism. Chaudhry et al (2017) showed that the heart rate-work load relationship is 
abnormal with increasing burden of coronary atheroma [27].  
One of the major advantages of CPEX is its ability to identify non-obstructive coronary artery 
disease, where the patient has physiologically significant atheroma burden, but with non-
obstructive arteries on angiography [28]. The PROMISE study showed the importance of 
diagnosing non-obstructive coronary artery atheroma, as it is associated with worse outcomes 
[29]. Microvascular coronary disease is one form of non-obstructive disease that predominantly 
affects women, with increased mortality and morbidity [30]. Chaudhry et al showed that CPEX 
could diagnose microvascular ischemia in the setting of exertional chest pain and normal 
coronary angiography[31]. Further medical therapy with anti-anginal Ranolazine improved the 
exercise capacity, as shown by rise in peak VO2 and O2/ΔWR slope. Hence CPEX could play 
a pivotal role in distinguishing microvascular angina from a false positive exercise ECG test, 
both being common amongst women.  
CPEX is proving to be an excellent prognostic marker as well. The prevalence of myocardial 
ischaemia is shown to be lower in those who achieve ≥10 metabolic equivalents during exercise 
testing [32]. Kavanagh et al showed that every 1ml/kg/min advantage of peak VO2, lowered 
mortality by 10% in those with known coronary artery disease[33]. In patients who underwent 







<16.3 ml/kg/min and a high VE/VCO2 slope of >36.2 are shown to predict adverse events [34]. 
There is evidence to show that in suspected myocardial ischemia, those presenting with 
dyspnoea have higher mortality than those presenting with typical or atypical angina [35]. 
CPEX has shown to be a valuable tool in investigating dyspnoea and guiding the physician to 
specific investigations [5, 36].  
In the ORBITA trial, revascularisation of significant single vessel coronary stenosis did not 
result in improvement in peak oxygen consumption [34]. Even in those with multi-vessel 
disease undergoing percutaneous coronary intervention after myocardial infarction, there 
seems to be no difference in peak oxygen consumption between those who underwent complete 
or incomplete revascularisation [37]. These studies suggest that epicardial stenosis may not be 
the only factor to determine exercise capacity, and the importance moving away from stenosis-
centric attitude in the treatment of coronary artery disease [28].  
The presence of a LBBB ECG pattern complicates the investigation of angina in stable 
outpatients. LBBB pattern is known to be associated with cardiomyopathy, conduction system 
abnormalities and coronary artery disease [38]. In those with LBBB pattern, exercise ECG 
testing is not useful in detecting ischaemia and myocardial perfusion imaging and dobutamine 
stress echocardiography are only of limited value, as the abnormal septal motion makes the 
image analysis difficult [39]. Case-2 showed appropriate heart rate and blood pressure response 
to exercise, the oxygen uptake and O2 pulse progressively increased throughout exercise ruling 
out a failing heart and there was no flattening of O2 pulse or O2/ΔWR to suggest coronary 
ischaemia. We believe CPEX can play an important role in this situation, avoiding complex 








CPEX does not differentiate microvascular from macrovascular coronary disease [40]. The 
oxygen-work uptake ‘relationship’ of 10 ml/min/Watt cannot be translated to treadmill exercise 
[12, 41]. Attempts to use just O2 pulse without VO2/ΔWR relationship have shown to be less 
useful in investigating angina, especially in those with a lower ischaemic burden [42]. 
Therefore, a treadmill CPEX is less effective when ischaemia is suspected. CPEX is more 
sensitive in triple vessel disease than in double and single vessel disease [8, 9]. This could be 
rather advantageous, as MPI can miss ‘balanced ischaemia’ in left main stem or triple vessel 
coronary disease [2, 43]. Co-existing conditions that interfere with oxygen delivery, like 
anaemia, lung disease, pulmonary vascular disease and heart failure could affect the accuracy 
of ischaemia detection by CPEX [44].  
Safety aspects in performing CPEX test: 
Complications can occur during or immediately after exercise testing. The risk of death with 
CPEX testing is very low, 1 in 20,000 (0.005%) and the risk of death or major adverse event 
(death or hospitalisation) is 1 in 10,000 (0.01%) [45]. Absolute contraindications to perform 
CPEX test are only a handful- recent myocardial infarction (< 5 days), acute respiratory or 
cardiac failure, severe symptomatic valvular stenosis, aortic dissection, acute pulmonary 
embolism and uncontrolled arrhythmias causing haemodynamic compromise [46]. While 
physician supervision is advised in high risk patients (recent myocardial infarction but >5 days, 
cardiac arrhythmia or  asymptomatic severe valvular stenosis), two physiologists or specialist 
nurses trained to recognise the complications and administer cardio-pulmonary resuscitation,  
can conduct most tests safely [5]. Continuous ECG monitoring, and blood pressure 
measurement every two minutes are mandatory during the exercise test and should continue 








Ischaemia detection is one of the novel applications of CPEX. The sensitivity and specificity 
of CPEX seem to be inferior to stress imaging techniques, but superior to exercise ECG testing. 
More importantly, it can guide therapy in those presenting with dyspnoea and provide 
prognostic information. CPEX can be valuable tool in those with LBBB pattern, and suspected 
microvascular ischemia. While recent guideline has recognised CPEX as an ischemia testing 
tool [48], it is yet to be inducted into routine clinical practice. Future research could explore 
combined a scoring system based on CPEX parameters and non-invasive imaging in diagnosis 
and prognosis of coronary artery disease.  
 
Summary points: 
• CPEX increases sensitivity and specificity for detection of myocardial ischaemia 
compared to standard exercise ECG test  
• CPEX is particularly useful when patients present with coronary artery disease present 
with breathlessness as their primary symptom 
• CPEX can play a unique role in assessment of myocardial ischaemia in special 
circumstances including LBBB, without exposing patients to the risks of coronary 
angiography 
• CPEX is an excellent prognostic marker in stable coronary artery disease and after acute 
myocardial infarction 
• New studies continue to identify novel CPEX prognostic markers in coronary artery 
disease.  
• A scoring system based on CPEX and another non-invasive imaging modality (like 
exercise echocardiography) can prove to be an excellent tool in the management of 
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A: Abrupt flattening of oxygen uptake, and B: abrupt flattening of oxygen pulse at peak exercise 
(markers of ischaemia and reduction in stroke volume). Paradoxical rise in O2 pulse in early recovery 
(resulting from improved cardiac function due to relief of ischaemia) 
VO2, body oxygen uptake; VCO2, Carbon-dioxide exhaled from the body (ml/min); HR, heart rate; 





A: Steady increase in absolute oxygen consumption throughout exercise. B: Steady increase in O2 
pulse, suggesting that there is no significant reduction in stroke volume during exercise. C: Oxygen 



















(reproduced with Permission from Belardinelli et al (2003), Oxford University press[8]) 
 
A: In a healthy subject (closed circles) O2 pulse steadily increases during incremental exercise and 
plateaus close to peak exercise. In an ischemic subject (open circles) the O2 pulse plateaued early 
(arrow) 
B: In the healthy subject (closed circles) the O2/ΔWR relationship is linear. In an ischemic subject 
(open circles), the O2/ΔWR is flattened at the inflection point (arrow).  
Both changes in the ischemic subject occurred at the same time, reflecting myocardial dyskinesis 






































RER-Respiratory Exchange Ratio; VO2- oxygen consumption; VE-ventilation; VCO2-carbon dioxide 

















 Rest AT Peak Predicted 
RER - 0.79 1.22 >1.15 
VO2 [ml/min] 579  1900 2738 127%  
VO2 [ml/min/kg] 5.6 18.3 26.3  
VE/VCO2 slope - 28.4 - <32 
Ventilation [L/min] 18.6 47.2 121.9  
MVV [L/min] - - - 136.8 
BR [litres] - - 14.9 >15 
Heart rate [bpm] 57  100 134 86% 
Blood pressure 
[mmHg] 
140/90 - 170/90 - 
























RER-Respiratory Exchange Ratio; VO2- oxygen consumption; VE-ventilation; VCO2-carbon dioxide 

















 Rest AT Peak Predicted 
RER - 0.91 1.12 >1.15 
VO2 [ml/min] - 836 1735 124%  
VO2 [ml/min/kg] - 11.6 24.1  
VE/VCO2 slope - 29 - <32 
Ventilation [L/min] 11.2 - 66.6 - 
MVV [L/min] - - - 93.2 
BR [litres] - - 26.6 >15 
Heart rate [bpm] 85 - 166 86% 
Blood pressure [mmHg] 133/74 - 187/93 - 
Resting oxygen 
saturations [%] 







































VO2 (oxygen uptake) Amount of oxygen consumed by the body per unit time 
VCO2 Amount of carbon dioxide exhaled from the body per unit 
time (ml/minute) 
Peak VO2 Highest VO2 achieved during maximal effort 
(may be expressed as an absolute value (ml/min) or 
corrected for weight (ml/kg/min)) 
Oxygen pulse Oxygen consumed by the body, per heartbeat. This depends 
on stroke volume and skeletal muscle oxygen extraction 
(ml/beats per minute) 
RER (Respiratory 
Exchange Ratio) 
Ratio of carbon dioxide output to oxygen uptake 
(VCO2/VO2) at a particular time during exercise 
Anaerobic threshold 
(AT) 
Exercise limit above which the subject’s anaerobic high 
energy phosphate production supplements aerobic 
metabolism. This time-point during exercise is identified by 
raising levels of carbon dioxide production, reflecting the 
serum raise in lactic acid 
VE Minute ventilation. Volume of air inhaled or exhaled by the 
body in 1 minute 




The maximum potential ventilation achievable (estimated 
as FEV1 x 40) 
BR 
(Breathing Reserve) 
The difference between maximum voluntary ventilation and 


















































2 1 2 3 4 5 6 7 8 3 
Gradient 0% 1% 2% 3% 4% 5% 6% 7% 8% 0% 
